VANCOUVER, BC, Feb. 11, 2015 (GLOBE NEWSWIRE) -- via PRWEB - According to a new extensive survey of hundreds of physicians that was conducted by iData Research (http://www.idataresearch.com), nearly half of surveyed orthopedic surgeons who attended the AAOS (American Academy of Orthopaedic Surgeons) Conference see a benefit to using custom joint implants.
"The AAOS Conference is a great opportunity to understand what goes into a surgeon's decision to use one type of joint implant over another," explains Dr. Kamran Zamanian, CEO of iData. "We're lucky enough to see international attendance at this conference, which gives us a world-wide perspective on the end-users within the billion-dollar joint restoration market."
Survey results demonstrate the growing demand for patient-specific implants among physicians. Provided that other factors are favorable, such as pricing, economics, and availability, this demand will help facilitate growth of the market for custom implant instrumentation and cutting blocks. The remainder of survey respondents were split between those who do not see a benefit to using customized implants, and those who had no opinion on the topic.
Underlying Reasons for Orthopedic Surgeon Preferences
Many surgeons gave unique feedback as to why, or why not, they choose to employ custom implants. The option to provide better implant fit and individualization for anatomical differences ranked highly. However, ease-of-use for custom implants was not a prevalent reason.
Surgeons who attended the AAOS conference were strongly motivated to provide the best clinical efficacy possibly for patients undergoing orthopedic surgery. That said, stock implants, those without the same tailoring possibilities as with custom implants, are often adequate for many surgeons. A diverse range of stock implant options are available on the market.
Internationally, orthopedic surgeons show a strong focus on procedure results, instead of on factors like cost reduction. If another product was able to demonstrate better clinical efficacy in comparison to the current product in use, many surgeons indicated that they would switch products. This trend was present from respondents across all geographical regions and clinical settings.
More Information on iData Research and the AAOS Conference
The next AAOS Conference is scheduled to be held in Las Vegas, Nevada, March 24 through 28.
Survey information presented here is available from iData published survey report entitled Global Orthopedic Implant Physician Preference Survey. Regions included are North America, Latin America, the Caribbean, Europe, the Middle East, Africa, Russia, East Asia, Southeast Asia and Oceania. Survey covers osteoarthritis treatment preferences and product preferences which spans knee, hip, hand digit, foot digit, cervical interbody, and thoracolumbar products, as well as custom implants.
Receive a free synopsis of the Global Orthopedic Implant Physician Preference Survey.
Request an Executive Summary or Table of Contents for iData's related reports: the Small Bone and Joint Orthopedic Device Market, including markets for shoulder reconstruction, elbow repair, staple fixation, and hand, wrist, foot, and ankle devices; or the Large Bone and Joint Orthopedic Device Market, which includes markets for knee and hip devices as well as bone cement.
About Procedure Tracker
Procedure number data is available from iData's Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by State, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.
About iData Research
iData Research (http://www.idataresearch.com) is an international market research and consulting goup focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Diabetes Drugs, Diabetes Devices, Pharmaceuticals, Anesthesiology, Wound Management, Orthopedics, Cardiovascular, Ophthalmics, Endoscopy, Gynecology, Urology and more.
This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2015/02/prweb12509081.htm